Vivid
Device Ultrasound
PDI 00195278505330
General payments
$110,434
Research payments
$434,317
Through program year 2025, $110,434 in general payments and $434,317 in research payments were reported against Vivid (Ultrasound).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $28,694 | 10 |
| 2024 | General | $46,845 | 14 |
| 2024 | Research | $261,419 | 17 |
| 2023 | General | $29,233 | 17 |
| 2023 | Research | $67,845 | 2 |
| 2022 | General | $5,662 | 3 |
| 2022 | Research | $105,053 | 2 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
44 general · 21 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.